1 Introduction to Research & Analysis Reports
1.1 Hemostatic Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemostatic Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemostatic Product Overall Market Size
2.1 Global Hemostatic Product Market Size: 2022 VS 2029
2.2 Global Hemostatic Product Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemostatic Product Players in Global Market
3.2 Top Global Hemostatic Product Companies Ranked by Revenue
3.3 Global Hemostatic Product Revenue by Companies
3.4 Top 3 and Top 5 Hemostatic Product Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hemostatic Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemostatic Product Players in Global Market
3.6.1 List of Global Tier 1 Hemostatic Product Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemostatic Product Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Hemostatic Product Market Size Markets, 2022 & 2029
4.1.2 Hemostasis Products for Trauma
4.1.3 Hemostasis Products for Surgery
4.1.4 Hemostasis Products for Hemophilia
4.1.5 Hemostasis Products for Myocardial Infarction
4.1.6 Others
4.2 By Type – Global Hemostatic Product Revenue & Forecasts
4.2.1 By Type – Global Hemostatic Product Revenue, 2018-2023
4.2.2 By Type – Global Hemostatic Product Revenue, 2024-2029
4.2.3 By Type – Global Hemostatic Product Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hemostatic Product Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Hemostatic Product Revenue & Forecasts
5.2.1 By Application – Global Hemostatic Product Revenue, 2018-2023
5.2.2 By Application – Global Hemostatic Product Revenue, 2024-2029
5.2.3 By Application – Global Hemostatic Product Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Hemostatic Product Market Size, 2022 & 2029
6.2 By Region – Global Hemostatic Product Revenue & Forecasts
6.2.1 By Region – Global Hemostatic Product Revenue, 2018-2023
6.2.2 By Region – Global Hemostatic Product Revenue, 2024-2029
6.2.3 By Region – Global Hemostatic Product Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Hemostatic Product Revenue, 2018-2029
6.3.2 US Hemostatic Product Market Size, 2018-2029
6.3.3 Canada Hemostatic Product Market Size, 2018-2029
6.3.4 Mexico Hemostatic Product Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Hemostatic Product Revenue, 2018-2029
6.4.2 Germany Hemostatic Product Market Size, 2018-2029
6.4.3 France Hemostatic Product Market Size, 2018-2029
6.4.4 U.K. Hemostatic Product Market Size, 2018-2029
6.4.5 Italy Hemostatic Product Market Size, 2018-2029
6.4.6 Russia Hemostatic Product Market Size, 2018-2029
6.4.7 Nordic Countries Hemostatic Product Market Size, 2018-2029
6.4.8 Benelux Hemostatic Product Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Hemostatic Product Revenue, 2018-2029
6.5.2 China Hemostatic Product Market Size, 2018-2029
6.5.3 Japan Hemostatic Product Market Size, 2018-2029
6.5.4 South Korea Hemostatic Product Market Size, 2018-2029
6.5.5 Southeast Asia Hemostatic Product Market Size, 2018-2029
6.5.6 India Hemostatic Product Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Hemostatic Product Revenue, 2018-2029
6.6.2 Brazil Hemostatic Product Market Size, 2018-2029
6.6.3 Argentina Hemostatic Product Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Hemostatic Product Revenue, 2018-2029
6.7.2 Turkey Hemostatic Product Market Size, 2018-2029
6.7.3 Israel Hemostatic Product Market Size, 2018-2029
6.7.4 Saudi Arabia Hemostatic Product Market Size, 2018-2029
6.7.5 UAE Hemostatic Product Market Size, 2018-2029
7 Hemostatic Product Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Hemostatic Product Major Product Offerings
7.1.4 Medtronic Hemostatic Product Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Hemostatic Product Major Product Offerings
7.2.4 Johnson & Johnson Hemostatic Product Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Baxter International
7.3.1 Baxter International Company Summary
7.3.2 Baxter International Business Overview
7.3.3 Baxter International Hemostatic Product Major Product Offerings
7.3.4 Baxter International Hemostatic Product Revenue in Global Market (2018-2023)
7.3.5 Baxter International Key News & Latest Developments
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Company Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Hemostatic Product Major Product Offerings
7.4.4 Pfizer Inc. Hemostatic Product Revenue in Global Market (2018-2023)
7.4.5 Pfizer Inc. Key News & Latest Developments
7.5 Becton Dickinson and Company (BD)
7.5.1 Becton Dickinson and Company (BD) Company Summary
7.5.2 Becton Dickinson and Company (BD) Business Overview
7.5.3 Becton Dickinson and Company (BD) Hemostatic Product Major Product Offerings
7.5.4 Becton Dickinson and Company (BD) Hemostatic Product Revenue in Global Market (2018-2023)
7.5.5 Becton Dickinson and Company (BD) Key News & Latest Developments
7.6 B. Braun Melsungen AG
7.6.1 B. Braun Melsungen AG Company Summary
7.6.2 B. Braun Melsungen AG Business Overview
7.6.3 B. Braun Melsungen AG Hemostatic Product Major Product Offerings
7.6.4 B. Braun Melsungen AG Hemostatic Product Revenue in Global Market (2018-2023)
7.6.5 B. Braun Melsungen AG Key News & Latest Developments
7.7 Tricol Biomedical
7.7.1 Tricol Biomedical Company Summary
7.7.2 Tricol Biomedical Business Overview
7.7.3 Tricol Biomedical Hemostatic Product Major Product Offerings
7.7.4 Tricol Biomedical Hemostatic Product Revenue in Global Market (2018-2023)
7.7.5 Tricol Biomedical Key News & Latest Developments
7.8 Hemostasis LL
7.8.1 Hemostasis LL Company Summary
7.8.2 Hemostasis LL Business Overview
7.8.3 Hemostasis LL Hemostatic Product Major Product Offerings
7.8.4 Hemostasis LL Hemostatic Product Revenue in Global Market (2018-2023)
7.8.5 Hemostasis LL Key News & Latest Developments
7.9 Teleflex Incorporated
7.9.1 Teleflex Incorporated Company Summary
7.9.2 Teleflex Incorporated Business Overview
7.9.3 Teleflex Incorporated Hemostatic Product Major Product Offerings
7.9.4 Teleflex Incorporated Hemostatic Product Revenue in Global Market (2018-2023)
7.9.5 Teleflex Incorporated Key News & Latest Developments
7.10 CuraMedical BV
7.10.1 CuraMedical BV Company Summary
7.10.2 CuraMedical BV Business Overview
7.10.3 CuraMedical BV Hemostatic Product Major Product Offerings
7.10.4 CuraMedical BV Hemostatic Product Revenue in Global Market (2018-2023)
7.10.5 CuraMedical BV Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
世界の止血製品市場予測2023-2029：外傷用止血製品、手術用止血製品、血友病用止血製品、心筋梗塞用止血製品、その他 |
| 【英語タイトル】Hemostatic Product Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU4923 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：62 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の止血製品市場規模と予測を収録しています。・世界の止血製品市場：売上、2018年-2023年、2024年-2029年 ・世界の止血製品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の止血製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「外傷用止血製品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 止血製品のグローバル主要企業は、Medtronic、 Johnson & Johnson、 Baxter International、 Pfizer Inc.、 Becton Dickinson and Company (BD)、 B. Braun Melsungen AG、 Tricol Biomedical、 Hemostasis LL、 Teleflex Incorporated、 CuraMedical BVなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、止血製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の止血製品市場：タイプ別、2018年-2023年、2024年-2029年 世界の止血製品市場：タイプ別市場シェア、2022年 ・外傷用止血製品、手術用止血製品、血友病用止血製品、心筋梗塞用止血製品、その他 世界の止血製品市場：用途別、2018年-2023年、2024年-2029年 世界の止血製品市場：用途別市場シェア、2022年 ・病院、クリニック、その他 世界の止血製品市場：地域・国別、2018年-2023年、2024年-2029年 世界の止血製品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における止血製品のグローバル売上、2018年-2023年 ・主要企業における止血製品のグローバル売上シェア、2022年 ・主要企業における止血製品のグローバル販売量、2018年-2023年 ・主要企業における止血製品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medtronic、 Johnson & Johnson、 Baxter International、 Pfizer Inc.、 Becton Dickinson and Company (BD)、 B. Braun Melsungen AG、 Tricol Biomedical、 Hemostasis LL、 Teleflex Incorporated、 CuraMedical BV ************************************************************* ・調査・分析レポートの概要 止血製品市場の定義 市場セグメント 世界の止血製品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の止血製品市場規模 世界の止血製品市場規模：2022年 VS 2029年 世界の止血製品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの止血製品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の止血製品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：外傷用止血製品、手術用止血製品、血友病用止血製品、心筋梗塞用止血製品、その他 止血製品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、その他 止血製品の用途別グローバル売上・予測 ・地域別市場分析 地域別止血製品市場規模 2022年と2029年 地域別止血製品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medtronic、 Johnson & Johnson、 Baxter International、 Pfizer Inc.、 Becton Dickinson and Company (BD)、 B. Braun Melsungen AG、 Tricol Biomedical、 Hemostasis LL、 Teleflex Incorporated、 CuraMedical BV ... |
Products for hemostasis, including physical hemostasis, chemical hemostasis, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Product. This report contains market size and forecasts of Hemostatic Product in global, including the following market information:
Global Hemostatic Product Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hemostatic Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hemostasis Products for Trauma Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemostatic Product include Medtronic, Johnson & Johnson, Baxter International, Pfizer Inc., Becton Dickinson and Company (BD), B. Braun Melsungen AG, Tricol Biomedical, Hemostasis LL and Teleflex Incorporated, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemostatic Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostatic Product Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hemostatic Product Market Segment Percentages, by Type, 2022 (%)
Hemostasis Products for Trauma
Hemostasis Products for Surgery
Hemostasis Products for Hemophilia
Hemostasis Products for Myocardial Infarction
Others
Global Hemostatic Product Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hemostatic Product Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Hemostatic Product Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hemostatic Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostatic Product revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hemostatic Product revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Johnson & Johnson
Baxter International
Pfizer Inc.
Becton Dickinson and Company (BD)
B. Braun Melsungen AG
Tricol Biomedical
Hemostasis LL
Teleflex Incorporated
CuraMedical BV
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemostatic Product, market overview.
Chapter 2: Global Hemostatic Product market size in revenue.
Chapter 3: Detailed analysis of Hemostatic Product company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemostatic Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の止血製品市場予測2023-2029：外傷用止血製品、手術用止血製品、血友病用止血製品、心筋梗塞用止血製品、その他] (コード：MMG23JU4923)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の止血製品市場予測2023-2029：外傷用止血製品、手術用止血製品、血友病用止血製品、心筋梗塞用止血製品、その他]についてメールでお問い合わせ |
